Clinically Proven Benefits
The development process for pre-Conceive took over three years to complete.
When the formulation was finally ready, the founder commissioned an independent clinical examination of the formula to see if it could correct fertility issues in men and women.
The results of this study, a landmark example of the importance of nutrition in reproductive health led to the company motto; Research – Evidence – Results.

The Participants
The highly regarded research team conducted a robust study by setting strict criteria in the recruitment process. 40 people / 20 couples were identified in Ireland.
- The average age was 37
- Each one of the 40 participants were diagnosed as infertile twice in a 12 month period - meaning a male and female factor issue
- The participants were at various stages of their infertility journeys, including those who had failed assisted reproduction treatments.

The Protocol
The protocol for the trial was developed to reflect the user-experience of pre-Conceive at home.
Each individual was provided with three boxes of pre-Conceive, to take for ninety days. They also met with an independent nutritional therapist who presented all participants with five dietary and lifestyle modifications.
At the end of their ninety-day course, they returned to the clinic to provide new samples for examination.
Female Participants
We wanted to demonstrate that pre-Conceive could improve the quality of the reproductive cycle, allowing for conception to ensue. In doing so, we focused on the participants hormonal profile, their AMH levels, and key fertility markers associated with fertility, conception, implantation and miscarriage, as well as the nutritional markers involved in these processes.

Female Results
After the three month pre-Conceive course, the tests were again carried out and found that:
- 100% of our applicants improved their hormonal profile, a monumental shift in supporting their reproductive processes,
- 71.43% of Women improved their AMH levels,
- 60% of women improved in the antioxidant marker Superoxide Dismutase (Protects follicle and egg quality),
- 60% of women improved the antioxidant marker Glutathione Peroxidase (Improves fertilisation and conception rates),
- there were improvements in B12, Folate and Vitamin D3 levels.
"The Anti-Mullerian Hormone (AMH) is a general indicator of the state of ovarian reserve in women. It appears that many women in the group were below, or close to, the lower threshold levels. It appears to be very much age related and very difficult to accurately quantify. It appears that 71.43% of women had an improvement in their levels over the period. In my opinion, PillarHealthcare’s pre-Conceive product is the best available for a single dose material.”
Dr. David Smallbone
Male Participants
The experts wanted to demonstrate that pre-Conceive could improve male fertility markers allowing for conception to ensue. The focus was on: the number of sperm cells being produced, the overall quality of the sperm cells, as well as improving the all-important DNA package within the sperm cells, improving both natural conception and assisted reproduction.

Male Results
After the 90 day course, a full semen analysis, an examination into DNA fragmentation, as well as general blood-work showed:
- 85% of men improved their Progressive Motility
- 79% of men improved their Total Motility
- 71% improved their Overall Sperm Count
- 81% showed improvements in the DNA of their sperm cells
- 66% of men improve their morphology
- 82% of men improved the antioxidant marker Glutathione Peroxidase
“pre-Conceive consciously provides those specific nutritional needs for full fertility health to be achieved. It may be that, inmost cases, very little else is required – except time."
Dr. David Smallbone